Related Experiment Videos
Cost of treatment of congenital dislocation of the hip
G Kernohan1, B Trainor, R Mollan
1Queen's University of Belfast, Musgrave Park Hospital, Northern Ireland.
Insights
Screening for congenital dislocation of the hip (CDH) in infants is cost-effective. Early detection by 6 months prevents complicated, expensive treatments, justifying screening program costs.
Area of Science:
- Pediatric Orthopedics
- Public Health
- Health Economics
Background:
- Congenital dislocation of the hip (CDH) requires timely intervention for optimal outcomes.
- Delayed diagnosis of CDH beyond 6 months leads to complex and costly treatment regimens.
- Effective screening programs are crucial for early detection and management of pediatric hip conditions.
Purpose of the Study:
- To evaluate the potential cost-savings associated with screening programs for congenital dislocation of the hip.
- To determine the economic impact of late diagnosis and treatment of CDH.
- To provide evidence supporting the financial viability of early CDH detection initiatives.
Main Methods:
- Analysis of treatment costs for 36 late-diagnosed cases of congenital dislocation of the hip from 1980.
- Calculation of the average cost per case for managing late-stage CDH.
- Comparison of late-treatment costs with potential screening program expenditures.
Main Results:
- The average treatment cost for late-diagnosed congenital dislocation of the hip was found to be £6,674 per case.
- This substantial cost highlights the financial burden of delayed diagnosis and intervention.
- The study indicates that this expenditure could be reallocated to fund effective screening programs.
Conclusions:
- Implementing early screening for congenital dislocation of the hip is a cost-effective public health strategy.
- Early detection significantly reduces the long-term financial burden associated with complex CDH treatments.
- Investment in screening programs for CDH is justifiable based on the potential for significant cost savings.
Abstract:
Early treatment for congenital dislocation of the hip is usually simple and inexpensive. However, if the disease is not detected by 6 months of age, treatment is often complicated and expensive. We evaluated the potential cost-saving of screening, by examining the costs in 36 late cases born in 1980 and found an average cost of pounds 6,674 per case for treatment to this date. This amount could justifiably be spent on each case detected in an effective screening programme.